Targeting IL-1, IL-6 or GM-CSF in COVID-19. Response to: 'More evidences on which biologic and which pathway is key in severe-critical COVID-19 pneumonia' by Ferraccioli.
Emanuel Della-TorreCampochiaro CorradoGiulio CavalliGiacomo De LucaFabio CiceriAlberto ZangrilloLorenzo DagnaPublished in: Annals of the rheumatic diseases (2020)